Funder: Crohn's and Colitis Foundation
Due Dates: March 2, 2026 (Year Two renewal) | December 1, 2026 (Pre-Application) | January 28, 2027 (Invited full proposal)
Funding Amounts: Up to $130,000 USD annually for clinical studies or $110,000 USD annually for laboratory-based studies; one year initially, with a competitive second-year renewal
Summary: Supports innovative, early-stage clinical and translational IBD research with potential to improve patient diagnosis, treatment, management, or prevention in the near future.
Key Information: Applicants must hold a faculty appointment at a nonprofit charitable institution; institutions worldwide are eligible.
Description
Litwin IBD Pioneers, formerly the Broad Medical Research Program, is a Crohn's and Colitis Foundation initiative supporting pioneering pilot research on Crohn's disease and ulcerative colitis. It helps scientists test initial ideas and generate preliminary data for clinically relevant diagnostic and therapeutic improvements. Investigators experienced in IBD and researchers entering from other disciplines are welcome.
The program supports clinical trials, observational clinical studies, biomarker identification, and evaluation of novel therapeutic approaches. Translational proposals should clearly connect to findings and observations in IBD patients. Preference goes to work involving patients or patient material with strong potential for foreseeable clinical application. Basic disease-mechanism studies in animal models or in vitro systems are not typically prioritized. Preliminary data are not required.
